41 companies we recorded at ASCO 2026
These are the companies Bounce Watch has picked up as having been at ASCO 2026 in Chicago, gathered from what they announced publicly. Each is listed with what it does and the date we recorded it, and the list stays up after the event closes. It is not the official exhibitor list — an event this size had many more companies than we saw, so read it as who we caught, not a roster.
Our record
There were almost certainly more — this is what we detected from public announcements.
- Speaking
- 26
- Exhibiting
- 10
- Attending
- 9
We track them daily and tell you what changes.
Who we saw at ASCO 2026
SOPHiA GENETICS
Switzerland · 2011
Democratizing Data-Driven Medicine, Together!
Recorded 4 May 2026
Expansion Announced · 18 Sep 2026
Tempus AI
United States · 2015
Tempus AI, Inc. (NASDAQ: TEM) is a technology company leading the adoption of AI to advance precision medicine.
Recorded 27 May 2026
New Feature Launched · 14 Sep 2026
HiRO - Harvest Integrated Research Organization
United States · 2020
Streamline & Accelerate Cross-border Clinical Trial Pathways
Recorded 27 May 2026
New Feature Launched · 2 Jun 2026
Invivyd
United States · 2020
Vaccines can only take us so far. Antibodies are the natural next step.
Recorded 9 Jun 2026
Expansion Announced · 24 Jun 2026
Cureety
France · 2018
Cureety is the European leader in oncology care, with therapy-specific intelligence and coordinated care workflows.
Recorded 28 May 2026
Made Acquisition · 2 Sep 2026
Novartis
Switzerland · 1996
Reimagining medicine by transforming cancer
Recorded 29 May 2026
Regulatory Approval · 31 Jul 2026
Veracyte, Inc.
United States · 2008
Cancer Genomic Testing & Molecular Diagnostics | Veracyte Inc.
Recorded 27 May 2026
New Product Launched · 1 Jun 2026
Viz.ai
United States · 2016
AI-powered disease detection and care coordination platform
Recorded 29 Apr 2026
New Product Launched · 14 May 2026
Adela, Inc.
United States · 2020
Advancing the field of epigenomics to transform how cancer is detected and monitored.
Recorded 1 Jun 2026
Growth Metrics Shared · 26 May 2026
AstraZeneca
United Kingdom · 1913
Biopharmaceutical solutions for major global diseases
Recorded 4 Jun 2026
Award Received · 29 Jul 2026
AOA Dx
United States · 2020
Transforming Women’s Health with Breakthrough Cancer Diagnostics and AI
Recorded 6 May 2026
Accepted to Program · 13 May 2026
ONCOCROSS Co., Ltd.
Korea South · 2015
AI, drug discovery development, biotechnology, indication expansion, rare disease, intractable disease, oncology, CUP
Recorded 21 Apr 2026
Acquired · 20 Apr 2026
BioInvent International AB
Sweden · 1983
BioInvent is translating cancer antibody biology into innovative immuno-oncology therapies.
Recorded 11 Jun 2026
Regulatory Approval · 4 Mar 2026
PathAI
United States · 2016
Improving patient outcomes with AI-powered pathology.
Recorded 28 May 2026
Award Received · 17 Jun 2026
Foundation Medicine
United States · 2010
A precision medicine company transforming lives in cancer and beyond.
Recorded 4 Jun 2026
New Product Launched · 3 Jun 2026
OXFORD VACMEDIX UK LIMITED
United Kingdom · 2012
Developing therapeutic cancer vaccines using ROP technology
Recorded 2 Jun 2026
Fundraising Intent · 23 Apr 2026
Synamics Therapeutics
United States · 2023
AI-powered therapeutics for treatment-resistant cancer
Recorded 15 May 2026
Fundraising Intent · 19 Jun 2026
Kite Pharma
United States · 2009
At Kite, a Gilead Company, our singular focus is cell therapy to treat and cure cancer.
Recorded 5 Jun 2026
New Product Launched · 26 May 2026
Memorial Sloan Kettering Cancer Center
United States · 1884
Recorded 2 Jun 2026
Grant Received · 8 Jun 2026
Pyxis Oncology
United States · 2019
Charting a course to therapeutics for difficult-to-treat cancer.
Recorded 28 May 2026
Fundraising Intent · 13 May 2026
Convergent Therapeutics, Inc.
United States · 2021
Developing next-generation targeted combination therapies to advance the care of cancer patients.
Recorded 21 May 2026
Key Hire Announced · 29 Apr 2026
Genmab
Denmark · 1999
Differentiated human antibody therapeutics for the treatment of cancer
Recorded 1 Jun 2026
Regulatory Approval · 6 Jul 2026
Telix Pharmaceuticals Limited
Australia · 2015
See it. Treat it.
Recorded 3 Jun 2026
Expansion Announced · 12 Jun 2026
InduPro
United States · 2022
Proximity by design
Recorded 27 May 2026
Key Hire Announced · 27 May 2026
Imugene Limited
Australia · 2013
Bringing Effective New Treatments And Options To Patients Who Need Them
Recorded 5 Jun 2026
Regulatory Approval · 11 Jun 2026
Akari Therapeutics, Plc
United Kingdom · 2015
Advancing Next-Generation Antibody Drug Conjugates Designed with Novel ImmunoOncology Payloads
Recorded 4 Jun 2026
Fundraising Intent · 28 May 2026
Zentalis Pharmaceuticals
United States · 2014
Clinical oncology innovator developing an investigational WEE1 inhibitor for ovarian cancer and multiple tumor types
Recorded 30 May 2026
Board Appointment · 27 May 2026
Predicine
United States · 2015
Advancing precision medicine through next-generation liquid biopsy oncology platform
Recorded 29 May 2026
Regulatory Approval · 14 May 2026
Philogen S.p.A.
Italy · 1996
Innovating Targeting
Recorded 10 Jun 2026
Award Received · 18 Mar 2026
Vir Biotechnology, Inc.
United States · 2016
Powering the Immune System to Transform Lives
Recorded 30 May 2026
Board Appointment · 10 Jun 2026
Exelixis
United States · 1994
Exelixis works on discovering, developing, and commercializing therapies for the treatment of cancer
Recorded 30 May 2026
Award Received · 4 Jun 2026
Perspective Therapeutics
· 2023
Game-changing therapies that make an impactful difference for cancer patients and the clinicians who treat them.
Recorded 29 May 2026
Regulatory Approval · 3 Jun 2026
Mindpeak
Germany · 2018
Our mission is to enable personalised cancer treatment through AI tissue diagnostics
Recorded 20 May 2026
New Product Launched · 3 Jun 2026
Cogent Biosciences
United States · 2014
Precision therapeutics for genetically defined diseases. Real solutions for real challenges.
Recorded 29 May 2026
Regulatory Approval · 28 May 2026
OrsoBio
United States · 2021
Advancing first-in-class therapies to restore energy homeostasis
Recorded 1 Jun 2026
Award Received · 18 Feb 2026
EvolveImmune Therapeutics
United States · 2020
Reimagining Cancer Immunotherapy
Recorded 8 Jun 2026
ImmunityBio, Inc.
United States · 2014
Outsmart Your Disease™
Recorded 29 May 2026
IDEAYA Biosciences
United States · 2015
Synthetic lethality precision medicine oncology company pursuing– an emerging class of precision medicine targets.
Recorded 29 May 2026
Salubris Biotherapeutics
United States · 2016
Recorded 1 Jun 2026
Stelexis BioSciences, Inc.
United States · 2017
Recorded 2 Jun 2026
Antares Therapeutics
Transforming patient lives through pioneering precision medicines
Recorded 1 Jun 2026
No company matches that.
What changed at these 41 companies recently?
We recorded 166 changes here in the last 180 days, including 51 product launches, 23 traction updates, 23 awards, 20 milestones and 15 expansion moves. Each entry below carries the date we observed it, from public sources.
-
SOPHiA GENETICS
— Expansion Announced
-
Tempus AI
— New Feature Launched
-
Cureety
— Made Acquisition
-
Novartis
— Regulatory Approval
-
AstraZeneca
— Award Received
-
Genmab
— Regulatory Approval
-
Invivyd
— Expansion Announced
-
Synamics Therapeutics
— Fundraising Intent
Other events we have a record for — see all
Following companies, not just one event?
Name the companies you care about and we watch them every day, then tell you what changed.